GlassScriptPhysician profile
Jared L Michalson
NPI 1295943579
$3,916.15
in general payments reported to CMS, 2019-2025
12 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $29.98 · 2021: $946 · 2022: $172 · 2023: $1,090 · 2024: $418 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Travel and Lodging: $797 · Entertainment: $32.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.61 |
| Travel and Lodging | $797.19 |
| Entertainment | $32.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,949.76 | 2019-2025 | Taylor Spatial Frame, Evos, Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $813.70 | 2019-2025 | Affixus, Rosa, Avenir |
| Stryker Corporation | $577.67 | 2021-2025 | Gamma, T2 Alpha, Axsos |
| Radius Health, INC. | $125.00 | 2019 | |
| Depuy Synthes Sales INC. | $117.70 | 2020-2021 | |
| Medacta USA, INC. | $114.47 | 2019 | |
| Bioventus LLC | $67.13 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Gemini Mountain Medical, LLC | $47.86 | 2025 | |
| Argentum Medical | $32.01 | 2024 | |
| Fidia Pharma USA INC. | $24.54 | 2024 | Hymovis, Triluron, Hyalgan |
| Pacira Pharmaceuticals Incorporated | $23.45 | 2025 | Exparel |
| Acera Surgical, INC. | $22.86 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Michalson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.